Treatment of Bipolar Disorder in Youth

Size: px
Start display at page:

Download "Treatment of Bipolar Disorder in Youth"

Transcription

1 Treatment of Bipolar Disorder in Youth Janet Wozniak, M.D. Associate Professor of Psychiatry Director, Pediatric Bipolar Disorder Research Program Harvard Medical School Massachusetts General Hospital

2 My spouse/partner and I have the following relevant financial relationship with a commercial interest to disclose: Merck/Schering-Plough research funding SPOUSE : Associated Professional Sleep Societies, Gerson Lerman Group, Summer Street Partners, UCB, Cantor Colburn Cambridge University Press consultation fees royalties

3 National Trends in Visits with a Diagnosis of Bipolar Disorder as a Percentage of Total Office-Based Visits This increase highlights a need for clinical epidemiological reliability studies to determine the accuracy of clinical diagnoses Moreno et al., Arch Gen Psych, 2007

4 Disruptive Mood Dysregulation Disorder DMDD Criteria A. The disorder is characterized by severe recurrent temper outbursts that are grossly out of proportion in intensity or duration to the situation. 1. The temper outbursts are manifest verbally and/or behaviorally, such as in the form of verbal rages or physical aggression towards people or property. 2. The temper outbursts are inconsistent with developmental level. B. Frequency: The temper outbursts occur, on average, three or more times per week. C. Mood between temper outbursts: 1. Nearly every day, most of the day, the mood between temper outbursts is persistently irritable or angry. 2. The irritable or angry mood is observable by others (e.g., parents, teachers, peers). D. Duration: Criteria A-C have been present for 12 or more months. Throughout that time, the person has not had 3 or more consecutive months when they were without the symptoms of Criteria A-C. E. Criterion A or C is present in at least two settings (at home, at school, or with peers) and must be severe in at least in one setting. F. The diagnosis should not be made for the first time before age 6 or after age 18. G. The onset of Criteria A through E is before age 10 years.

5 The New Temper Tantrum Disorder Will the new diagnostic manual for psychiatrists go too far in labeling kids dysfunctional? By David Dobbs Posted Friday, Dec. 7, 2012, at 1:12 PM ET Published May 2013 American Psychiatric Association's Diagnostic Statistical Manual, Fifth Edition, or DSM-5

6 Bipolar I or II Disorder affected 2.9% of >10,000 adolescents, most with severe impairment

7 Merikangas, et al, National Comorbidity Survey Replication-Adolescent Supplement, 2010

8 SCOPE OF THE PROBLEM Meta-analysis of Epidemiologic Studies of Pediatric Bipolar Disorder Van Meter J Clin Psych 2011

9 Pediatric-Onset Bipolar Disorder Do children look different? Irritability and Fluctuating Mood States/Mixed States Less euphoria (or hard to detect?) AFFECTIVE STORMS SEVERELY Irritable: swearing, disrespectful, threatening, wild, out of control With Explosions: frequent, for minutes, destructive, aggressive Lower level Irritable: whiney, complaining, difficult to please, angry, grouchy, cranky, snappy Chronicity and?rapid Cycling Discrete episodes may be difficult to delineate Ultradian Cycling or changes in mood presentation/ polarity Developmental Distinctions in Symptoms What s grandiosity? What s hypersexuality? Spending?

10 Euphoria and Irritability in BPD Probands Euphoric N=5 Irritable N=23 N=38 Euphoric, Any = 28 Irritable, Any = 61 82% (23 of 28) of Euphoric subjects met for Irritability 38% (23 of 61) of Irritable subjects met for Euphoria

11 Kraepelin s Depressed, Mixed and Manic Across the Life span Kraepelin. Manic Depressive Insanity Page 168 (Figure 45). Translated by RM Barclay. GM Robertson (ed). E & S Livingstone, Edinburgh.

12 Developmental Course in Bipolar Children: A disorder affecting preschoolers Children often ill for years by time of referral Mean Age at Onset Bipolar Onset (4.55) ADHD ANX ODD MDD CD

13 Mania Episodicity (N = 92) Youth are both episodic and chronic % % Rapid Cycling > 4 episodes/yr 27% Ultra-Rapid 20 episodes/yr 1% Ultraradian 300 episodes/yr 7% Episodic, 12 m Presentation varies: mixed, manic, depressed Mood switches: irritable, euphoric, melancholy Comorbidity evident % Single, 12 m 10 5% Episodic, < 12 m 0 7% Single, < 12 m Chronic Episodic

14 Pediatric-Onset Bipolar Disorder: Why is it Underdiagnosed? The symptoms of ADHD and mania overlap and are difficult to disentangle Talkativeness, hyperactivity (physical agitation/energy), distractibility are symptoms of ADHD and mania ADHD is a common disorder of childhood (5-10%) and often includes emotional dysregulation

15 MGH Study of Pediatric BPD Comorbid Disorders by Bipolar Cohort, Clinic Samples Prior to 1995 and P = NS P = NS Bipolar 1st Cohort Bipolar 2nd Cohort P = NS 80 % P = NS P = NS Major Depression Psychosis ADHD Oppostional Defiant Disorder Conduct Disorder Psychiatric Diagnoses

16 Meta-Analysis of 5 Controlled Family Studies of Pediatric Bipolar Disorder These odds ratios indicate a risk of bipolar I disorder to relatives of bipolar I probands that is 4-14 times greater than the risk to relatives of nonbipolar probands NO EVIDENCE OF HETEROGENEITY IN MAGNITUDE OF FAMILIAL TRANSMISSION Wozniak J Clin Psych, 2012

17 Familial risk of bipolar I disorder in first-degree relatives of BP-I, ADHD and Control Probands Morbid risk in relatives * Proband n = Relative n = Wozniak J Clin Psych, 2012

18 Persistence: Most bipolar adults in STEP-BD (N=983) reported onset in childhood or adolescence About 65% of adults with onset < 18 Almost a third with onset <13 > 18 years: 35% < 13 years 28% 13 to 18 years 37% Perlis, Miyahara, Marangell, Wisniewski, Ostacher, DelBello, Bowden, Sachs, Nierenberg, Biol Psych 2004;55:

19 Pediatric Bipolar Disorder Persistence Child Bipolar I Disorder Prospective Continuity With Adult Bipolar I Disorder; Characteristics of Second and Third Episodes; Predictors of 8- Year Outcome Conclusions: In grown-up subjects with child BP-I, the 44.4% frequency of manic episodes was 13 to 44 times higher than population prevalences, strongly supporting continuity. Geller, et al, Arch Gen Psychiatry, 2008;65(10):

20 Persistence of Pediatric Bipolar Disorder Four-Year Longitudinal Course of Children and Adolescents With Bipolar Spectrum Disorders: The Course and Outcome of Bipolar Youth (COBY) Study N=214 Bipolar I and N=169 Bipolar II and NOS, followed for 4 years with the Longitudinal Interview Follow Up Evaluation Recurrences common Symptomatic on average for 60% of the follow-up period. 40% had symptoms during 75% of the followup period. 25% of BPD II and 38% of BPD NOS converted to BPI Birmaher, et al, Am J Psychiatry Jul;166(7):

21 Persistence of Pediatric Bipolar Disorder HIGH LEVEL OF PERSISTENCE OF PEDIATRIC BIPOLAR-I DISORDER FROM CHILDHOOD ONTO ADOLESCENT YEARS: A FOUR YEAR PROSPECTIVE 78 of 105 youth with Bipolar I disorder followed up after 3.6 years Baseline age 10.5 years, 76% male Age of onset bipolar disorder 4.9 years Duration of BPD at baseline 7.6 years Wozniak et al, J Psychiatr Res, 2011

22 Persistence of Bipolar Disorder in youth at 4-year Follow-up (N=78) Most continue with Bipolar I disorder 73.1% Better 6.4% Better, but Treated 9.0% Some symptoms of Mania 6.4% Not manic, but depressed 5.1% Only 5 (6.4%) subjects were better without treatment Wozniak et al, J Psychiatr Res, 2011

23 Off-Label Use All medications, described in this presentation constitute offlabel use in the USA with the exception of the following FDA approved medications: Fluoxetine: depression and OCD age 8+ Escitalopram: depression age 12+ Sertraline,fluvoxamine, anfranil: pediatric OCD

24 Off-Label Use All medications, described in this presentation constitute off-label use in the USA with the exception of the following FDA approved medications: Lithium: manic or mixed states, patients aged years 2007 Risperidone: manic or mixed states, age years 2008 Aripiprazole: manic or mixed states, age years 2009 Olanzapine: manic or mixed states, age years 2009 Quetiapine: monotherapy or adjunct to lithium or divalproex sodium, manic states, age years 2015 Saphris manic or mixed episodes assoc with BPD I, age 10-17

25 Off-Label Use All medications, described in this presentation constitute off-label use in the USA with the exception of the following FDA approved medications: Aripiprazole: irritability associated with autistic disorder ages 6-17 Risperidone: irritability associated with autism ages 5-16

26 Treatment algorithm Stage I monotherapy +/- augmentation Stage 2 switch monotherapy agent Stage 3 combo mood stabilizer + SGA (Or switch monotherapy agent) Stage 4 Combination 1 mood stabilizer + SGA 2 mood stabilizers + SGA Stage 5 alternate monotherapy Stage 6 ECT vs. Clozapine Kowatch, JAACAP, 2005

27 Can we wait? Post, Leverich, et al

28 Bipolar adults with childhood and adolescent onset had more lifetime suicide attempts and violence N= Child Adolescent Adult Suicide Attempts Violence Psychotic Features Perlis, Miyahara, Marangell, Wisniewski, Ostacher, DelBello, Bowden, Sachs, Nierenberg, Biol Psych 2004;55:

29 Number of Subjects Participating in Pediatric Anti-Manic Trials J Am Acad Child Adolesc Psychiatry, 2011;50(8):

30 Mean Change in YMRS from Baseline by Medication Class Traditional Mood Stabilizers Other Anticonvulsants Atypical Antipsychotics Naturopathic Treatments YMRS Score

31 Weight Gain in 8-week Open Label Trials of Second Generation Antipsychotic Monotherapy in 116 Children with Bipolar Disorder 06 aripiprazole quetiapine Change from Baseline (kg) 05 risperidone ziprasidone 04 olanzapine Biederman et al (2007), AACAP; Boston

32 Adverse Events Weight gain and metabolic risks associated with antipsychotic medications in children and adolescents N=34 studies olanzapine 3.8 to 16.2 kg clozapine kg risperidone kg quetiapine kg aripiprazole kg (n=353) (n=97) (n=571) (n=133) (n=451) Correll et al JChildAdolescPsychopharm 2011 Dec;21(6):517-35

33 Adverse Events One-year incidence rates of tardive dyskinesia in children and adolescents treated with second-generation antipsychotics: a systematic review Correll, et al JChildAdolescPsychopharm 2007;17(5): N=783 Results across 10 studies suggest relatively low 1-year TD rates in pediatric patients treated with SGAs. However, the available data base is limited by the small sample size of studies with SGAs other than risperidone and by the use of relatively low doses, which may have obscured a potentially greater risk for TD in children and adolescents treated with higher total SGA doses and for longer durations. Three new cases of TD emerged during long-term treatment with SGAs of up to 3 years, resulting in crude and annualized TD rates of 0.38%. In the two cases with information, TD resolved within weeks after antipsychotic discontinuation.

34 Adverse Events Pringsheim T, Lam D, Ching H, Patten S. Metabolic and neurological complications of second-generation antipsychotic use in children. Drug Saf. 34(8), (2011).

35 Lithium, Divalproex Sodium, and Carbamazepine in Bipolar Disorder Kowatch et al. JAACAP 39, , 2000 Results The response rates were 53% for divalproex sodium 38% for lithium 38% for carbamazepine All 3 mood stabilizers were well tolerated with no serious adverse effects

36 Pediatric Bipolar Disorder: Progress in Treatments A prospective open-label trial of lamotrigine monotherapy in children and adolescents with bipolar disorder. J.CNS Neurosci Ther A prospective open-label trial of extendedrelease carbamazepine monotherapy in children with bipolar disorder. JCAP 2010

37 This study was highly publicized in the major news media and suggest that 2 months of supplementation can have positive effects after one year on psychotic symptoms

38 Our own study shows that omega-3s can treat bipolar disorder in children This result is about 50% what we see with atypical antipsychotic medications, but without the serious or annoying side effects

39 Comorbid disorders Depression- after mania stabilized Lithium, Lamotrigine, or bupropion Avoid SSRI s ADHD Stimulant after mood stabilized Joshi G, Wilens TE. Child Adolesc Psych Clin N Am 18 (2009) Comorbidity in PBD

40 Quetiapine not effective in Adolescent Bipolar Depression Mean (SD) change in CDRS-R scores from baseline to endpoint DelBello et al., 2009

41 Open Label Lamotrigine and Lithium Effective in Adolescent Bipolar Depression Chang et al JAmAcadChildAdolPsyc 2006 N=20 Adjunctive or monotherapy lamotrigine 63% responders (at least 50% decrease in CDRS) 84% much or very much improved CGI-I Patel et al JAmAcadChildAdolPsyc 2006 N=27 Monotherapy Lithium 48% responders (at least 50% decrease in CDRS)

42 Treatment of ADHD comorbid with Pediatric BPD Some SGA studies of bipolar disorder in youth also demonstrate improvement of ADHD (eg, paliperidone, joshi et al 2013; Aripiprazole, Tramontina 2007, 2009; Risperidone, Biederman 2008) One study correlated the improvement of ADHD with the improvement in mania In a chart review of risperidone, mania improved, but not ADHD (Frazier 1999) In studies of Equetro (Joshi 2010) and lamotrigine (Biederman, 2010), mania, depression and ADHD all improved

43 Treatment of ADHD comorbid with Pediatric BPD Improvement in ADHD shown in two add-on studies: Adderall v placebo, 4 week study, Scheffer 200 Methylphenidate v placebo, 4 week study, Findling 2007 However, methylphenidate v placebo in youth stabilized with Abilify showed no differences in improvement in ADHD. Zeni, Chart review of Strattera demonstrated improvement in ADHD symptoms in stabilized bipolar subjects, Chang wk open trial adjunct treatment in euthymic youth demonstrated improvement, Chang 2009

44 Treatment of ADHD comorbid with Pediatric BPD N=22,797 cases diagnosed with pediatric ADHD odds of developing BD were significantly and positively associated with: -- longer treatment with methylphenidate, mixed amphetamine salts, or atomoxetine being -- treatment with certain antidepressant medications, most notably fluoxetine, sertraline, bupropion, trazodone or venlafaxine Jerrell JM, J Clin Psychiatry.

45 Euthymic youths with bipolar disorder and ADHD may benefit from short-term concomitant treatment with methylphenidate A 4-week double-blind, placebo-controlled trial in youths ages 5 to 17 years with bipolar disorder and ADHD, were currently receiving a stable dose of at least one thymoleptic, and while euthymic continued to have clinically significant symptoms of ADHD. Patients received 1 week each of placebo, methylphenidate 5 mg twice daily, methylphenidate 10 mg twice daily, and methylphenidate 15 mg twice daily using a crossover design. Subjects were randomly assigned to receive one of six possible dosing orders. The primary outcome measure was the total score on the parent-completed ADHD RESULTS Lower scores during best dose treatment compared to the week of placebo treatment were found on the ADHD Rating Scale-IV (p <.05), suggesting a therapeutic benefit. A large effect size (Cohen's d = 0.90) was found for methylphenidate. Treatment was generally well tolerated. Rating Scale-IV. Findling et al., J. Am. Acad. Child Adolesc. Psychiatry, 2007;46(11):

46 Treatment of substance abuse comorbid with Pediatric BPD Lithium improved substance abuse, not bipolar, in comorbid pediatric subjects Geller, JAACAP, 1998

47 Treatment of autism comorbid with Pediatric BPD SGA secondary analysis of SGA trials demonstrated improvement of bipolar disorder in the autism subjects (Joshi, et al ) SGAs demonstrated improvement in ASD subjects (Hamrin, 2008; Atlas, 1995)

48 Pediatric Bipolar Disorder Treatment Summary Atypical antipsychotic agents outperform traditional mood stabilizers and other anticonvulsants Emerging evidence to support combination pharmacotherapy or natural treatments Highly comorbid, so combined therapies routine Depression difficult to treat

49 Future Research Questions Studies of young children < 12 years old and preschoolers Combination pharmacotherapy trials Pharmacotherapy of comorbid disorders ADHD Depression OCD Psychosocial treatment

50 Massachusetts General Hospital Department of Psychiatry Presents 39 th Annual Psychopharmacology Conference THURSDAY-SUNDAY, OCTOBER 22-25, 2015 THE WESTIN COPLEY PLACE BOSTON, MA MGHCME.ORG Psychopharmacology 39 th Annual Psychopharmacology Conference Friday, September Thursday 28 Sunday, October September 22 25, 30, The Westin Copley Place

Bipolar Disorder in Youth

Bipolar Disorder in Youth Bipolar Disorder in Youth Janet Wozniak, M.D. Associate Professor of Psychiatry Director, Pediatric Bipolar Disorder Research Program Harvard Medical School Massachusetts General Hospital Pediatric-Onset

More information

Severe Mood Dysregulation in Children and Adolescents Research Findings Support Diagnostic Validity of Pediatric Bipolar Disorder

Severe Mood Dysregulation in Children and Adolescents Research Findings Support Diagnostic Validity of Pediatric Bipolar Disorder Severe Mood Dysregulation in Children and Adolescents Research Findings Support Diagnostic Validity of Pediatric Bipolar Disorder Janet Wozniak, M.D. Associate Professor of Psychiatry Director, Pediatric

More information

Pediatric Bipolar Disorder: Advances in Diagnosis and Research

Pediatric Bipolar Disorder: Advances in Diagnosis and Research Pediatric Bipolar Disorder: Advances in Diagnosis and Research Janet Wozniak, M.D. Associate Professor of Psychiatry Director, Pediatric Bipolar Disorder Research Program Harvard Medical School Massachusetts

More information

Pediatric Bipolar Disorder and ADHD

Pediatric Bipolar Disorder and ADHD Pediatric Bipolar Disorder and ADHD Janet Wozniak, M.D. Director, Pediatric Bipolar Disorder Research Program Associate Professor Psychiatry Massachusetts General Hospital Harvard Medical School Disclosures

More information

Pediatric Bipolar Disorder and ASD

Pediatric Bipolar Disorder and ASD Pediatric Bipolar Disorder and ASD Janet Wozniak, MD Associate Professor of Psychiatry Massachusetts General Hospital Disclosures My spouse/partner and I have the following relevant financial relationship

More information

Differentiating Unipolar vs Bipolar Depression in Children

Differentiating Unipolar vs Bipolar Depression in Children Differentiating Unipolar vs Bipolar Depression in Children Mai Uchida, M.D. Director, Center for Early Identification and Prevention of Pediatric Depression Massachusetts General Hospital Assistant Professor

More information

Handout for the Neuroscience Education Institute (NEI) online activity: Juvenile Bipolar Disorder: Further Complicated by Comorbidity

Handout for the Neuroscience Education Institute (NEI) online activity: Juvenile Bipolar Disorder: Further Complicated by Comorbidity Handout for the Neuroscience Education Institute (NEI) online activity: Juvenile Bipolar Disorder: Further Complicated by Comorbidity Learning Objectives Utilize evidence-based strategies to accurately

More information

Practice Parameter for the Assessment and Treatment of Children and Adolescents with Bipolar Disorder,

Practice Parameter for the Assessment and Treatment of Children and Adolescents with Bipolar Disorder, Practice Parameter for the Assessment and Treatment of Children and Adolescents with Bipolar Disorder, Journal of the Academy of Child and Adolescent Psychiatry, 1997 Primary Authors: Jon McClellan MD

More information

5 COMMON QUESTIONS WHEN TREATING DEPRESSION

5 COMMON QUESTIONS WHEN TREATING DEPRESSION 5 COMMON QUESTIONS WHEN TREATING DEPRESSION Do Antidepressants Increase the Possibility of Suicide? Will I Accidentally Induce Mania if I Prescribe an SSRI? Are Depression Medications Safe and Effective

More information

Differentiating MDD vs. Bipolar Depression In Youth

Differentiating MDD vs. Bipolar Depression In Youth Differentiating MDD vs. Bipolar Depression In Youth Mai Uchida, M.D. Staff Physician Clinical and Research Programs in Pediatric Psychopharmacology Massachusetts General Hospital Disclosures Neither I

More information

D I A G N O S I S ADD/ADHD. Conduct Disorder. Oppositional. Oppositional Defiant Disorder. Defiant. Anxiety Disorder. Adjustment.

D I A G N O S I S ADD/ADHD. Conduct Disorder. Oppositional. Oppositional Defiant Disorder. Defiant. Anxiety Disorder. Adjustment. Dr. Crismon has no potential conflicts of interest to disclose with regard to this presentation. M. Lynn Crismon, Pharm.D., FCCP, BCPP Dean James T. Doluisio Regents Chair & Behrens Centennial Professor

More information

Index. Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) b-adrenergic blockers

Index. Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) b-adrenergic blockers Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) a-adrenergic blockers for PTSD, 798 b-adrenergic blockers for PTSD, 798 Adrenergic

More information

The Pharmacological Management of Bipolar Disorder: An Update

The Pharmacological Management of Bipolar Disorder: An Update Psychobiology Research Group The Pharmacological Management of Bipolar Disorder: An Update R. Hamish McAllister-Williams, MD, PhD, FRCPsych Reader in Clinical Psychopharmacology Newcastle University Hon.

More information

Pediatric Psychopharmacology

Pediatric Psychopharmacology Pediatric Psychopharmacology General issues to consider. Pharmacokinetic differences Availability of Clinical Data Psychiatric Disorders can be common in childhood. Early intervention may prevent disorders

More information

Deficits in Emotional Regulation in ADHD

Deficits in Emotional Regulation in ADHD Deficits in Emotional Regulation in ADHD Joseph Biederman, MD Professor of Psychiatry Harvard Medical School Chief, Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD Massachusetts

More information

5/2/2017. By Pamela Pepper PMH, CNS, BC. DSM-5 Growth and Development

5/2/2017. By Pamela Pepper PMH, CNS, BC. DSM-5 Growth and Development By Pamela Pepper PMH, CNS, BC DSM-5 Growth and Development The idea that diagnosis is based on subjective criteria and that those criteria should fall neatly into a set of categories is not sustainable,

More information

RANZCP 2010 AUCKLAND, NEW ZEALAND

RANZCP 2010 AUCKLAND, NEW ZEALAND RANZCP 2010 AUCKLAND, NEW ZEALAND Dr Veronica Stanganelli et al. RANZCP 2010 1 INTRODUCTION Bipolar disorder within young people has been debated for years. It is still controversial in DSM V (1), whether

More information

J. Indian Assoc. Child Adolesc. Ment. Health 2012; 8(1):1-5. Editorial

J. Indian Assoc. Child Adolesc. Ment. Health 2012; 8(1):1-5. Editorial 1 J. Indian Assoc. Child Adolesc. Ment. Health 2012; 8(1):1-5 Editorial Controversies in Paediatric Bipolar Disorder Vivek Agarwal 1, Sivakumar T 2 1.Editor JIACAM & Associate Professor, Department of

More information

Kelly E. Williams, Pharm.D. PGY2 Psychiatric Pharmacy Resident April 16,2009

Kelly E. Williams, Pharm.D. PGY2 Psychiatric Pharmacy Resident April 16,2009 Kelly E. Williams, Pharm.D. PGY2 Psychiatric Pharmacy Resident April 16,2009 List the antipsychotics most often prescribed Compare and contrast the use and adverse effects experienced in the pediatric

More information

Medications for Anxiety & Behavior in Williams Syndrome. Disclosure of Potential Conflicts. None 9/22/2016. Evaluation

Medications for Anxiety & Behavior in Williams Syndrome. Disclosure of Potential Conflicts. None 9/22/2016. Evaluation Medications for Anxiety & Behavior in Williams Syndrome Christopher J. McDougle, M.D. Director, Lurie Center for Autism Professor of Psychiatry and Pediatrics Massachusetts General Hospital and MassGeneral

More information

CHAIR SUMMIT 7TH ANNUAL #CHAIR2014. Master Class for Neuroscience Professional Development. September 11 13, Westin Tampa Harbour Island

CHAIR SUMMIT 7TH ANNUAL #CHAIR2014. Master Class for Neuroscience Professional Development. September 11 13, Westin Tampa Harbour Island #CHAIR2014 7TH ANNUAL CHAIR SUMMIT Master Class for Neuroscience Professional Development September 11 13, 2014 Westin Tampa Harbour Island Sponsored by #CHAIR2014 Bipolar Depression: Putting the End Goal

More information

Judges Reference Table for the March 2016 Psychotropic Medication Utilization Parameters for Foster Children

Judges Reference Table for the March 2016 Psychotropic Medication Utilization Parameters for Foster Children Judges Reference Table for the Psychotropic Medication Utilization Parameters for Foster Children Stimulants for treatment of ADHD Preschool (Ages 3-5 years) Child (Ages 6-12 years) Adolescent (Ages 13-17

More information

#CHAIR2016. September 15 17, 2016 The Biltmore Hotel Miami, FL. Sponsored by

#CHAIR2016. September 15 17, 2016 The Biltmore Hotel Miami, FL. Sponsored by #CHAIR2016 September 15 17, 2016 The Biltmore Hotel Miami, FL Sponsored by Pediatric Bipolar Disorder: Diagnosis and Management Karen Dineen Wagner, MD, PhD University of Texas Medical Branch Galveston,

More information

Bipolar disorder and severe irritability in youth: Diagnosis and treatment. Ellen Leibenluft, M.D.

Bipolar disorder and severe irritability in youth: Diagnosis and treatment. Ellen Leibenluft, M.D. Bipolar disorder and severe irritability in youth: Diagnosis and treatment Ellen Leibenluft, M.D. Chief, Section on Bipolar Spectrum Disorders Emotion and Development Branch National Institute of Mental

More information

Clinical Guideline for the Management of Bipolar Disorder in Adults

Clinical Guideline for the Management of Bipolar Disorder in Adults Clinical Guideline for the Management of Bipolar Disorder in Adults Goal: To improve the quality of life of adults with bipolar disorder Identification and Treatment of Bipolar Disorder Criteria for Diagnosis:

More information

Pharmacy Prior Authorization GMH/SA and Non-Title 19/21 SMI Non-Formulary and Prior Authorization Guidelines

Pharmacy Prior Authorization GMH/SA and Non-Title 19/21 SMI Non-Formulary and Prior Authorization Guidelines Non-Formulary Behavioral Health Medications ADHD medications for children under The patient must have a diagnosis for which the requested medication is: o Approved based on FDA indication and limits; OR

More information

CHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XIV, 2012 INDEX

CHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XIV, 2012 INDEX A Adderall Counterfeit, 31 addiction, internet CBT, 55 ADHD Adjunctive Guanfacine, 11 Counterfeit Adderall, 31 Developmental Trajectory and Risk Factors, 5 Dopamine Transporter Alterations, 14 Extended-Release

More information

Paediatric Psychopharmacology. Dr Jalpa Bhuta. MD, DNB, MRCPsych (UK).

Paediatric Psychopharmacology. Dr Jalpa Bhuta. MD, DNB, MRCPsych (UK). Paediatric Psychopharmacology. Dr Jalpa Bhuta. MD, DNB, MRCPsych (UK). Childhood pharmacokinetics Children have greater hepatic capacity More glomerular filtration Less fatty tissue Less ability to store

More information

BIPOLAR DISORDER AND ADHD IN CHILDREN

BIPOLAR DISORDER AND ADHD IN CHILDREN BIPOLAR DISORDER AND ADHD IN CHILDREN BIPOLAR I DISORDER IS BEING DIAGNOSED WITH INCREASING FREQUENCY (INTENSITY) IN PRE-PUBERTAL CHIDREN WITH THE CAVEAT (WARNING / STIPULATION) THAT CLASSIC MANIC EPISODES

More information

CHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XV, 2013 INDEX

CHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XV, 2013 INDEX A acceptance and commitment therapy Posttraumatic Stress, 69 ADHD Adjunctive Fatty Acids, 5 Adjunctive Guanfacine Pharmacokinetics, 27 Amantadine, 21 Atomoxetine, 23 Cancer Risk, 31 CBT for Comorbid Anxiety,

More information

Psychiatric Medications. Positive and negative effects in the classroom

Psychiatric Medications. Positive and negative effects in the classroom Psychiatric Medications Positive and negative effects in the classroom Teaching the Medicated Child Beverly Bryant, M.D. Hattiesburg Clinic 9/17/14 Introduction According to the National Survey of Children

More information

Disruptive mood dysregulation disorder (DMDD) a

Disruptive mood dysregulation disorder (DMDD) a Disruptive mood dysregulation disorder: A better understanding Recognizing key differences in DMDD can help distinguish it from similar pediatric disorders Disruptive mood dysregulation disorder (DMDD)

More information

Paediatric Bipolar Disorder & Transitions to adult services. Adi Sharma on behalf of ABS

Paediatric Bipolar Disorder & Transitions to adult services. Adi Sharma on behalf of ABS Paediatric Bipolar Disorder & Transitions to adult services Adi Sharma on behalf of ABS Talk Paediatric Bipolar Disorder [PBD]: Why bother DMDD Comorbidity and/or Differential Diagnoses: EUPD, ADHD & ASD

More information

Aggression (Severe) in Children under Age 6

Aggression (Severe) in Children under Age 6 Aggression (Severe) in Children under Age 6 Level 0 Comprehensive diagnostic assessments. Refer to Principles of Practice on page 6. Evaluate and treat comorbid conditions (i.e. medical, other psychiatric

More information

Preferred Practice Guidelines Bipolar Disorder in Children and Adolescents

Preferred Practice Guidelines Bipolar Disorder in Children and Adolescents BadgerCare Plus Preferred Practice Guidelines Bipolar Disorder in Children and Adolescents These Guidelines are based in part on the following: American Academy of Child and Adolescent Psychiatry s Practice

More information

Mood swings in young people

Mood swings in young people Mood swings in young people Bipolar I & II Disorders are uncommon before puberty; Mood Dysregulation (MD) is very common before puberty Are they the same problem? What are the beginnings of bipolar? What

More information

Class Update: Oral Antipsychotics

Class Update: Oral Antipsychotics Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119

More information

Psychotropic Medication Management in Children and Adolescents

Psychotropic Medication Management in Children and Adolescents Drug Use Research & Management Program DHS Division of Medical Assistance Programs, 500 Summer Street NE, E35; Salem, OR 97301-1079 Phone 503-947-5220 Fax 503-947-1119 Psychotropic Medication Management

More information

Treatment of Anxiety and Mood Disorders. John T. Walkup, MD Division of Child and Adolescent Psychiatry Weill Cornell Medical College New York, NY

Treatment of Anxiety and Mood Disorders. John T. Walkup, MD Division of Child and Adolescent Psychiatry Weill Cornell Medical College New York, NY Treatment of Anxiety and Mood Disorders John T. Walkup, MD Division of Child and Adolescent Psychiatry Weill Cornell Medical College New York, NY Disclosure: John T. Walkup, MD Consultant Advisory Board

More information

Criteria for Child Psychiatrist on the Use of Selected Psychotropic Medications in Children & Adolescents

Criteria for Child Psychiatrist on the Use of Selected Psychotropic Medications in Children & Adolescents Criteria for Child Psychiatrist on the Use of Selected Psychotropic Medications in Children & Adolescents DRUG NAME INDICATIONS / ACCEPTABLE USES PRIOR STIMULANT/ADHD DRUGS Daytrana (methylphenidate) ADHD

More information

What s New in Psychotropic Prescribing for Children: Trends, Guidelines & Practice

What s New in Psychotropic Prescribing for Children: Trends, Guidelines & Practice 3 rd Annual Challenges & Innovations in Rural Psychiatry Conference What s New in Psychotropic Prescribing for Children: Trends, Guidelines & Practice June 22, 2016 What s New in Psychotropic Prescribing

More information

Pediatric Bipolar Disorder

Pediatric Bipolar Disorder Pediatric Bipolar Disorder Jason J. Washburn, Ph.D., ABPP 1 Overview of Talk Bipolar Disorder Understanding Differences between Adults & Children Diagnosis of Pediatric Bipolar Disorder Treatment of Pediatric

More information

Treatment of Bipolar disorder

Treatment of Bipolar disorder 8/6/215 Treatment of Bipolar disorder Pichai Ittasakul, M.D. Department of Psychiatry, Ramathibodi Hospital, Mahidol University Bipolar disorder Manic-depressive Illness. is characterized by the occurrence

More information

Comprehensive Quick Reference Handout on Pediatric Bipolar Disorder By Jessica Tomasula

Comprehensive Quick Reference Handout on Pediatric Bipolar Disorder By Jessica Tomasula Comprehensive Quick Reference Handout on Pediatric Bipolar Disorder By Jessica Tomasula Official Name Bipolar Disorder; also referred to as Manic Depression Definitions (DSM-IV-TR, 2000) Bipolar I Disorder

More information

Disclosure Statement. A Rational Approach to Psychopharmacology. Goals 10/28/2013

Disclosure Statement. A Rational Approach to Psychopharmacology. Goals 10/28/2013 A Rational Approach to Psychopharmacology Disclosure Statement Full time employed physician with MaineGeneral Medical Center in Waterville and Augusta No conflicts of interest to disclose Goals Promote

More information

Piecing the Puzzle Together: Pharmacologic Approaches to Behavioral Management in Autism Spectrum Disorder

Piecing the Puzzle Together: Pharmacologic Approaches to Behavioral Management in Autism Spectrum Disorder Piecing the Puzzle Together: Pharmacologic Approaches to Behavioral Management in Autism Spectrum Disorder Hannah Sauer, PharmD PGY1 Pediatric Pharmacy Resident Mayo Clinic 2015 MFMER slide-1 Objectives

More information

PDF created with pdffactory Pro trial version

PDF created with pdffactory Pro trial version با ی د ر ا ر وه روا ز ش ی دا ه ع وم ش ی ا ان Treatment Challenges in BD Major depressive episode Mixed states= 20% Rapid cycling= 18% (annually), 31.5% (lifetime) Psychiatric Comorbidity (substance abuse,

More information

Things You Might Not Know About Psychotropic Medications But Wish You Did

Things You Might Not Know About Psychotropic Medications But Wish You Did Things You Might Not Know About Psychotropic Medications But Wish You Did John E. Dunne, MD December 3, 2016 PAL Conference Conflicts of Interest None to report I am employed by Seattle Children s and

More information

Disruptive Mood Dysregulation Disorder

Disruptive Mood Dysregulation Disorder Walden University ScholarWorks School of Counseling Publications College of Social and Behavioral Sciences 2015 Disruptive Mood Dysregulation Disorder Brandy L. Gilea Walden University Rachel M. O Neill

More information

Behavioral Health. Behavioral Health. Prescribing Guidelines

Behavioral Health. Behavioral Health. Prescribing Guidelines Behavioral Health Behavioral Health Prescribing Guidelines Attention Deficit/Hyperactivity Disorder (ADHD) Start with a first line medication, either from the methylphenidate or dextroamphetamine-amphetamine

More information

Empirical Evidence for the Use of Lithium and Anticonvulsants in Children with Psychiatric Disorders

Empirical Evidence for the Use of Lithium and Anticonvulsants in Children with Psychiatric Disorders REVIEW Empirical Evidence for the Use of Lithium and Anticonvulsants in Children with Psychiatric Disorders Melissa Lopez-Larson, MD, and Jean A. Frazier, MD Background: The use of psychotropic medications

More information

Depression in Adolescents PREMA MANJUNATH, MD CHILD AND ADOLESCENT PSYCHIATRIST

Depression in Adolescents PREMA MANJUNATH, MD CHILD AND ADOLESCENT PSYCHIATRIST Depression in Adolescents PREMA MANJUNATH, MD CHILD AND ADOLESCENT PSYCHIATRIST Francis Bacon Children sweeten labors, but they make misfortunes bitter. They increase the cares of life, but they mitigate

More information

3/19/2018. Cynthia King, MD Associate Professor of Psychiatry UNMSOM. Autism Spectrum Disorder

3/19/2018. Cynthia King, MD Associate Professor of Psychiatry UNMSOM. Autism Spectrum Disorder Cynthia King, MD Associate Professor of Psychiatry UNMSOM Autism Spectrum Disorder 1 Identify three behavioral health concerns in ASD Identify three common families of medication that may be supportive

More information

3/19/2018. Cynthia King, MD Associate Professor of Psychiatry UNMSOM

3/19/2018. Cynthia King, MD Associate Professor of Psychiatry UNMSOM Cynthia King, MD Associate Professor of Psychiatry UNMSOM 1 2 Autism Spectrum Disorder 3 Identify three behavioral health concerns in ASD Identify three common families of medication that may be supportive

More information

Diagnosis & Assessment in Pediatric Psychopharmacology

Diagnosis & Assessment in Pediatric Psychopharmacology Diagnosis & Assessment in Pediatric Psychopharmacology Joseph Biederman, MD Professor of Psychiatry Harvard Medical School Chief, Clinical and Research Programs in Pediatric Psychopharmacology and Adult

More information

Lithium in bipolar disorders.

Lithium in bipolar disorders. Lithium in bipolar disorders. S. Mehdi Samimi Ardestani M.D. Department of Psychiatry, Shahid Beheshti University of Medical Science, Behavioral science research center Iranian psychiatric association,

More information

Where to from Here? Evidence-Based Strategies for Treatment of Refractory Depression

Where to from Here? Evidence-Based Strategies for Treatment of Refractory Depression Where to from Here? Evidence-Based Strategies for Treatment of Refractory Depression Michael D. Jibson, MD, PhD Professor of Psychiatry University of Michigan Major Depression #1 WHO cause of disability

More information

7/9/2013. Psychiatric medication treatment in children and adolescents: The good, the bad and the ugly. What ADHD is

7/9/2013. Psychiatric medication treatment in children and adolescents: The good, the bad and the ugly. What ADHD is Psychiatric medication treatment in children and adolescents: The good, the bad and the ugly Gabrielle A. Carlson, MD Professor of Psychiatry and Pediatrics Director, Child and Adolescent Psychiatry Stony

More information

Pediatrics Grand Rounds 5 March University of Texas Health Science Center at San Antonio I-1

Pediatrics Grand Rounds 5 March University of Texas Health Science Center at San Antonio I-1 Diagnosis and Treatment of Depression in Children and Adolescents Steven R. Pliszka, M.D. Professor and Vice Chair Chief, Division of Child and Adolescent Psychiatry Department of Psychiatry The Disclosures

More information

BIPOLAR DISORDERS DIAGNOSTIC AND TREATMENT ISSUES RICHARD RIES MD

BIPOLAR DISORDERS DIAGNOSTIC AND TREATMENT ISSUES RICHARD RIES MD Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences BIPOLAR DISORDERS DIAGNOSTIC AND TREATMENT ISSUES RICHARD RIES MD PROFESSOR DEPARTMENT OF PSYCHIATRY UNIVERSITY

More information

Bipolar Disorder Clinical Practice Guideline Summary for Primary Care

Bipolar Disorder Clinical Practice Guideline Summary for Primary Care Bipolar Disorder Clinical Practice Guideline Summary for Primary Care DIAGNOSIS AND CLINICAL ASSESSMENT Bipolar Disorder is categorized by extreme mood cycling; manifested by periods of euphoria, grandiosity,

More information

Bipolar Disorder in Child Psychiatric Practice: A Case Report

Bipolar Disorder in Child Psychiatric Practice: A Case Report CASE REPORT Bipolar Disorder in Child Psychiatric Practice: A Case Report 1. 2, 2, * A. Tsarkov *, P. Petlovanyi 1 Chainama Hills College Hospital, Lusaka, Zambia 2 Department of Psychiatry, School of

More information

Department of Psychiatry & Behavioral Sciences. University of Texas Medical Branch

Department of Psychiatry & Behavioral Sciences. University of Texas Medical Branch Depression in Childhood: Advances and Controversies in Treatment Karen Dineen Wagner, MD, PhD Marie B. Gale Centennial Professor & Vice Chair Department of Psychiatry & Behavioral Sciences Director, Division

More information

ATTENTION DEFICIT HYPERACTIVITY DISORDER COMORBIDITIES 23/02/2011. Oppositional Defiant Disorder

ATTENTION DEFICIT HYPERACTIVITY DISORDER COMORBIDITIES 23/02/2011. Oppositional Defiant Disorder ATTENTION DEFICIT HYPERACTIVITY DISORDER COMORBIDITIES The comorbidity of ADHD with other disorders is between 60% and 80% The most commonly comorbid disorder that occur alongside ADHD are: Oppositional

More information

Challenges in identifying and treating bipolar depression: a guide

Challenges in identifying and treating bipolar depression: a guide Challenges in identifying and treating bipolar depression: a guide Dr. Paul Stokes Clinical Senior Lecturer, Centre for Affective Disorders, Department of Psychological Medicine Overview Challenges in

More information

Update on Pediatric Bipolar Disorder

Update on Pediatric Bipolar Disorder Update on Pediatric Bipolar Disorder Benjamin I. Goldstein, MD,, FRCPC Associate Professor Departments of Psychiatry & Pharmacology Sunnybrook Health Sciences Centre University of Toronto Faculty of Medicine

More information

Tools that make a difference in mental health symptoms of autistic spectrum children Sumru Bilge-Johnson M.D. Program Director of Child Psychiatry

Tools that make a difference in mental health symptoms of autistic spectrum children Sumru Bilge-Johnson M.D. Program Director of Child Psychiatry Tools that make a difference in mental health symptoms of autistic spectrum children Sumru Bilge-Johnson M.D. Program Director of Child Psychiatry Fellowship Associate Professor, Child Psychiatry NEOMED

More information

Forty-Eighth Annual Teaching Conference Pediatrics for the Practitioner -UT Health Science Center San Antonio School of Medicine June 10-12, 2011

Forty-Eighth Annual Teaching Conference Pediatrics for the Practitioner -UT Health Science Center San Antonio School of Medicine June 10-12, 2011 Adelaide Robb, MD Associate Professor Psychiatry and Pediatrics Source Advisory Board Disclosure Speaker s Bureau Bristol Myers Squibb Yes Yes Yes Epocrates Research Contract Royalties Yes Stock Janssen

More information

35-year-old woman with Hx of BPII Dx; currently separated from husband; has 1 child

35-year-old woman with Hx of BPII Dx; currently separated from husband; has 1 child Stephen M. Strakowski, MD Chart Review: Bipolar Disorder PATIENT INFO 35 Age: Female Sex: 35-year-old woman with Hx of BPII Dx; currently separated from husband; has 1 child Background: SI and hospitalization

More information

Psychiatric Disorders and Treatments in Children with VCFS

Psychiatric Disorders and Treatments in Children with VCFS Psychiatric Disorders in VCFS at Different Age Groups Psychiatric Disorders and Treatments in Children with VCFS Prof. Doron Gothelf, M.D. The Behavioral Neurogenetics Center Edmond & Lily Safra Children

More information

Mood Disorders and Addictions: A shared biology?

Mood Disorders and Addictions: A shared biology? Mood Disorders and Addictions: A shared biology? Dr. Paul Stokes Clinical Senior Lecturer, Centre for Affective Disorders, Department of Psychological Medicine Disclosures No relevant disclosures: No paid

More information

It's Cycling, Not Polarity Understanding and Diagnosing the Bipolar Spectrum

It's Cycling, Not Polarity Understanding and Diagnosing the Bipolar Spectrum It's Cycling, Not Polarity Understanding and Diagnosing the Bipolar Spectrum Session 4022: American Psychiatric Nurses Association National Conference, Louisville, KY Andrew Penn, RN, MS, NP, CNS Psychiatric

More information

Your footnote

Your footnote MANIA Your footnote Your footnote Cipriani A, Barbui C, Salanti G et al. Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis. The Lancet 2011;

More information

Medically Accepted Indications for Pediatric Use of Psychotropic Medications by

Medically Accepted Indications for Pediatric Use of Psychotropic Medications by Key: White Background: Medically Accepted Indication Yellow Backgroun: Medically Accepted Indication Status Not Ascertained Orange Background: Pediatric Indication cited, but not supported Red Background:

More information

Post Traumatic Stress Disorder (PTSD) versus Bipolar Disorder: Confusion in the face of chaos.

Post Traumatic Stress Disorder (PTSD) versus Bipolar Disorder: Confusion in the face of chaos. Post Traumatic Stress Disorder (PTSD) versus Bipolar Disorder: Confusion in the face of chaos. Randall Ricardi D.O. Child and Adolescent Psychiatry Phoenix Children s Hospital 6-24-17 10:50am Disclosures

More information

BIPOLAR DISORDERS UPDATE. Anthony Archer, DO

BIPOLAR DISORDERS UPDATE. Anthony Archer, DO BIPOLAR DISORDERS UPDATE Anthony Archer, DO OBJECTIVES Review the major developments and trends in diagnosis and management of bipolar disorders. Discuss and promote the role of the primary care physician

More information

PSYCHIATRY ALERTS CHILD& ADOLESCENT. Severe Mood Dysregulation or Bipolar Disorder?

PSYCHIATRY ALERTS CHILD& ADOLESCENT. Severe Mood Dysregulation or Bipolar Disorder? Aripiprazole Augmentation in OCD...69 CHILD& ADOLESCENT PSYCHIATRY ALERTS INDEX...70 Methylphenidate-Associated Priapism...68 Reference Guide...70 Severe Mood Dysregulation...67 Volume XII / December 2010

More information

Psychiatric medication treatment in children and adolescents:

Psychiatric medication treatment in children and adolescents: Psychiatric medication treatment in children and adolescents: The good, the bad and the ugly Gabrielle A. Carlson, MD Professor of Psychiatry and Pediatrics Director, Child and Adolescent Psychiatry Stony

More information

Major Depressive Disorder (MDD) in Children under Age 6

Major Depressive Disorder (MDD) in Children under Age 6 in Children under Age 6 Level 0 Comprehensive assessment. Refer to Principles of Practice on page 5. Level 1 Psychotherapeutic intervention (e.g., dyadic therapy) for 6 to 9 months; assessment of parent/guardian

More information

Childhood Rage: Diagnosis and Treatment Strategies for Severe Mood Dysregulation - Part 2: Diagnosis and Treatment

Childhood Rage: Diagnosis and Treatment Strategies for Severe Mood Dysregulation - Part 2: Diagnosis and Treatment Liberty University DigitalCommons@Liberty University Faculty Publications and Presentations Department for Counselor Education and Family Studies 2013 Childhood Rage: Diagnosis and Treatment Strategies

More information

The shift in nosology from the Diagnostic PROCEEDINGS FROM CHILDHOOD TO ADOLESCENCE: DIAGNOSIS AND COMORBIDITY ISSUES * Thomas J. Spencer, MD ABSTRACT

The shift in nosology from the Diagnostic PROCEEDINGS FROM CHILDHOOD TO ADOLESCENCE: DIAGNOSIS AND COMORBIDITY ISSUES * Thomas J. Spencer, MD ABSTRACT FROM CHILDHOOD TO ADOLESCENCE: DIAGNOSIS AND COMORBIDITY ISSUES * Thomas J. Spencer, MD ABSTRACT Attention-deficit/hyperactivity disorder (ADHD) tends to manifest differently in adolescents than in children,

More information

Treating Disruptive Behavior Disorders in Children and Teens. A Review of the Research for Parents and Caregivers

Treating Disruptive Behavior Disorders in Children and Teens. A Review of the Research for Parents and Caregivers Treating Disruptive Behavior Disorders in Children and Teens A Review of the Research for Parents and Caregivers e Is This Information Right for Me? This information is for you if: A health care professional*

More information

Current. A bad boy s behavior problems CASES THAT TEST YOUR SKILLS

Current. A bad boy s behavior problems CASES THAT TEST YOUR SKILLS Two weeks after changing medications, a hyperactive 11-year-old becomes manic and attempts suicide. Is the new regimen or an undiagnosed mental disorder to blame? A. Kenneth Fuller, MD Chief of psychiatry

More information

Bipolar Disorder 4/6/2014. Bipolar Disorder. Symptoms of Depression. Mania. Depression

Bipolar Disorder 4/6/2014. Bipolar Disorder. Symptoms of Depression. Mania. Depression Bipolar Disorder J. H. Atkinson, M.D. Professor of Psychiatry HIV Neurobehavioral Research Programs University of California, San Diego KETHEA, Athens Slides courtesy of John Kelsoe, M.D. Bipolar Disorder

More information

Manual of Clinical Psychopharmacology

Manual of Clinical Psychopharmacology Manual of Clinical Psychopharmacology Fourth Edition Alan F. Schatzberg, M.D. Kenneth T. Norris, Jr., Professor and Chairman, Department of Psychiatry and Behavioral Sciences, Stanford University School

More information

35-year-old woman with Hx of BPII Dx; currently separated from husband; has 1 child

35-year-old woman with Hx of BPII Dx; currently separated from husband; has 1 child Stephen M. Strakowski, MD Chart Review: Bipolar Disorder PATIENT INFO 35 Age: Female Sex: 35-year-old woman with Hx of BPII Dx; currently separated from husband; has 1 child Background: SI and hospitalization

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Single Technology Appraisal

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Single Technology Appraisal NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Single Technology Appraisal Aripiprazole for the treatment and prevention of acute manic and mixed episodes in bipolar disorder in children and adolescents

More information

Kelly Godecke, MD Department of Psychiatry University of Utah

Kelly Godecke, MD Department of Psychiatry University of Utah Kelly Godecke, MD Department of Psychiatry University of Utah Epidemiology and Impact -module 2 session 1 overview of mood disorders Diagnostic Criteria of Bipolar Disorders Medications Used in Bipolar

More information

White Paper: The Treatment of Schizophrenia and Bipolar Disorder

White Paper: The Treatment of Schizophrenia and Bipolar Disorder White Paper: The Treatment of Schizophrenia and Bipolar Disorder in Children: What is Medically Necessary? For Health Plans, Medical Management Organizations and TPAs Trends in the Diagnosis and Treatment

More information

Major Depressive Disorder (MDD) in Children under Age 6

Major Depressive Disorder (MDD) in Children under Age 6 in Children under Age 6 Level 0 Comprehensive assessment. Refer to Principles of Practice on page 6. Level 1 Psychotherapeutic intervention (e.g., dyadic therapy) for 6 to 9 months; assessment of parent/guardian

More information

Bipolar Disorder Demystified. Cerrone Cohen, MD FABPN, FABFM Duke Departments of Family Medicine and Psychiatry

Bipolar Disorder Demystified. Cerrone Cohen, MD FABPN, FABFM Duke Departments of Family Medicine and Psychiatry Bipolar Disorder Demystified Cerrone Cohen, MD FABPN, FABFM Duke Departments of Family Medicine and Psychiatry Underdiagnoses of Depression In Primary Care 2005 Study of 650 primary care patients on antidepressants

More information

Pharmacotherapy of ADHD with Non-Stimulants

Pharmacotherapy of ADHD with Non-Stimulants Pharmacotherapy of ADHD with Non-Stimulants Timothy E. Wilens, M.D. Chief, Division of Child and Adolescent Psychiatry, (Co)Director of Center for Addiction Medicine, Massachusetts General Hospital Massachusetts

More information

Big Lots Behavioral Health. Prescribing Guidelines for Behavioral Health

Big Lots Behavioral Health. Prescribing Guidelines for Behavioral Health Big Lots Behavioral Health Prescribing Guidelines for Behavioral Health Prescribing for Behavioral Health This document was developed by Nationwide Children s Hospital in conjunction with Partners For

More information

2013 Virtual AD/HD Conference 1

2013 Virtual AD/HD Conference 1 Medication for & Coexisting Conditions Part 2 Dr. Kenny Handelman Child, Adolescent & Adult Psychiatrist Halton Healthcare Adjunct Professor of Psychiatry, University of Western Ontario www.drkenny.com

More information

September 26 28, 2013 Westin Tampa Harbour Island. Co-sponsored by

September 26 28, 2013 Westin Tampa Harbour Island. Co-sponsored by September 26 28, 2013 Westin Tampa Harbour Island Co-sponsored by Best Practices in the Management of Bipolar Disorder Robert M. A. Hirschfeld, MD University of Texas Medical Branch Galveston, TX Peter

More information

Pharmacy Prior Authorization GMH/SA and Non-Title 19/21 SMI Non-Formulary and Prior Authorization Guidelines

Pharmacy Prior Authorization GMH/SA and Non-Title 19/21 SMI Non-Formulary and Prior Authorization Guidelines Brand Name Medication Requests Non-Formulary Medications GMH/SA and Non- 19/21 SMI Mercy Care requires use of generic agents that are considered therapeutically equivalent by the FDA. For authorization

More information

Pediatric Behavior Problems: ODD and DMDD. Stanley Brewer, DO Pediatrics Assistant Professor (Clinical) Psychiatry Adjunct Instructor

Pediatric Behavior Problems: ODD and DMDD. Stanley Brewer, DO Pediatrics Assistant Professor (Clinical) Psychiatry Adjunct Instructor Pediatric Behavior Problems: ODD and DMDD Stanley Brewer, DO Pediatrics Assistant Professor (Clinical) Psychiatry Adjunct Instructor Acting out: What to call it Externalizing disorders Oppositional Defiant

More information

Pharmacotherapy of ADHD with Non- Stimulants

Pharmacotherapy of ADHD with Non- Stimulants Pharmacotherapy of ADHD with Non- Stimulants Timothy E. Wilens, M.D. Chief, Division of Child and Adolescent Psychiatry, (Co)Director of Center for Addiction Medicine, Massachusetts General Hospital Massachusetts

More information

Medications and Children Disorders

Medications and Children Disorders Mental Health Comprehensive Services Providing Family Stability and Developing Life Coping Skills Medications and Children Disorders Psychiatric medications can be an effective part of the treatment for

More information